[1]CurrentPatentAssignee:BAYERAG-US2014/148433,2014,A1Locationinpatent:Paragraph1377;1378;1379;1380
[1]CurrentPatentAssignee:FORMATHERAPEUTICS,INC.-WO2015/74064,2015,A2Locationinpatent:Paragraph0577
73616-27-0
3702-13-4
3524-50-3
5346-53-2
1311314-01-8
1006469-41-5
52988-34-8 | 4'-Methoxybiphenyl-4-carboxaldehyde | AA00DE0O | MFCD01862517
5442-12-6 | Norcantharidin | AA00DE7M | MFCD00213361
500024-91-9 | N'-Hydroxy-1,5-dimethyl-1H-pyrrole-2-carboximidamide | AA00DEDV | MFCD03756659
54-88-6 | 4-DIMETHYLAMINO-2-METHYLAZOBENZENE | AA00DEL2 | MFCD00008306
53732-26-6 | 1-(2-Chloro-5-Methylphenoxy)-2,3-epoxypropane | AA00DERJ | MFCD11651661
53603-16-0 | HEXYL METHANETHIOSULFONATE | AA00DEYY | MFCD03425576
5026-42-6 | 5,10-Dihydro-5-Methyl-11H-dibenzo[b,e][1,4]diazepin-11-one | AA00DF5G | MFCD20260057
4847-29-4 | 5,5-Dimethyl-2-((2-phenoxyacetamido)methyl)thiazolidine-4-carboxylic acid | AA00DFBL | MFCD02683390
462068-15-1 | 6-Oxo-5,6-dihydro[1,3]dioxolo[4,5-g]quinoline-7-carbaldehyde | AA00DFIR | MFCD02596873
446866-83-7 | 3-(Morpholinomethyl)benzaldehyde | AA00DFS8 | MFCD07782413